WebMD2d
FDA Approves Zepbound for Obstructive Sleep Apnea
FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
WebMD5d
Feeling Blue? Holiday Lights Might Be the Cure
Mental health issues, such as depression and substance use, often peak during the holidays, but research has shown that just ...
WebMD8d
Nearly a Quarter of Americans Endured Chronic Pain Last Year
New CDC data shows that in a survey, 24% of adults said they had pain most days or every day during the past three months.
WebMD9d
Why Holiday Family Time Can Feel Like a Health Hazard
Does your family make you sick at the holidays? We’re not just talking about catching a bug. It’s the emotional toll, which ...
WebMD6d
FDA Approves New Drug for Advanced Lung Cancer
The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).
WebMD6d
U.S. Sees Rise in Life Expectancy After Pandemic Decline
COVID-19 continues to retreat from being a top cause of death in the U.S., and in turn, life expectancy last year rebounded further toward pre-pandemic longevity.
WebMD9d
FDA Approves New Drug for Advanced Skin Cancer
The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.